Biologics

Business

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform By Investing.com

MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company)…

Read More »
Back to top button